Navigation Links
SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
Date:10/17/2007

DUBLIN, Calif., Oct. 17 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that multiple abstracts have been accepted for poster presentations at the AACR-NCI-EORTC International Conference from Oct. 22-26 at the Moscone Center in San Francisco.

The poster presentations will focus on data concerning many of SuperGen's current oncology programs including the lead clinical compound, MP470, and its ability to suppress the repair of double stranded DNA breaks following treatment with DNA-damaging agents.

In addition to the poster presentations listed below, data on SuperGen's hypomethylating agent, S110, will be presented by Dr. Peter A. Jones on Wednesday, Oct. 24 at 8:00 a.m. in Plenary Session 3: Epigenetic Targets.

SuperGen's schedule of presentations is as follows:

Poster

Date Time (PDT) Abstract # and Title Number/Session

Tuesday, 12:30 p.m.- # 1026 - MP470 #A173

Oct. 23 2:30 p.m. suppresses repair of

double-strand breaks Poster Session A

5:30 p.m.- following treatment

7:30 p.m. with DNA-damaging

agents

Wednesday, 12:30 p.m.- # 1038 - The #B140

Oct. 24 2:30 p.m. decitabine-derived

demethylating Poster Session B

5:30 p.m.- dinucleotide, S110

7:30 p.m.
'/>"/>

SOURCE SuperGen Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Chennai AIDS Campaign Highlights The Social Neglect Faced By Victims
2. Benzene Slick In China Highlights Water Pollution
3. India To Highlight Its Scientific Achievements
4. Homecare Association Highlights Cost-Effectiveness of Medicare and Medicaid
5. India To Highlight The Potential Role Of Ayurveda In London
6. Study Highlights Appetite Regulation Pathway, New Hope for Weight Loss
7. Study Highlights How Bacteria Respond To Changes In Environment
8. Drug Action Week to Highlight Effects of Alcohol
9. Clinton, Gates Highlight Treatment, Discrimination of AIDS
10. Highlights from World Transplant Congress
11. Latest IPCC Report Highlights Need for Integrated Climate/human Behavior Models

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...lights positive influence of sports participation ..., IL (Vocus) November 9, 2009 -- As people age fra...research has highlighted the importance of exercis...sues. However, a new study published in the Novemb...linary Approach reveals that there may be signifi...
(Date:11/9/2009)...al Ambassador ,, WHITE PLAINS, N.Y., Nov. 9 /..., Fla., was born so early and with so many underde...he would survive -- or if he would ever walk, talk...ch of Dimes 2010 National Ambassador. ,, Joshu...es of motherhood and I was completely devastated. ...
(Date:11/9/2009)...m incapacitated to working again, , ,...mulation of a certain area of the brain may prove ...German researchers. , They implanted electrodes... people. This area of the brain is part of the re... experiences and puts them in a state of pleasant ...
(Date:11/9/2009)...re-USNewswire/ -- New Mayo Clinic research has fou...ramatically reduces patient hospital stay and reco... week at the North Central Section of the American..., (Logo: http://www.newscom.com/cgi-bin/prnh/200... audio and video resources, including excerpts fro...
(Date:11/9/2009)...our current campaign finance system ,, WASHING...Congress who noted "no" on health care reform legi...lion more in campaign donations from health insura... legislation to overhaul of the nation,s health ca...lition of campaign reform groups. ,, "The healt...
Breaking Medicine News(10 mins):Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3Health News:'No' Votes on Health Care Bill Received $2.3 Million More from Health Insurance Industry 2
...ase of H5N1 infection known as bird flu in a 19-ye...he man by his surname, Cheng, and said he was unde.... But it did not specify his unit or say ...d pneumonia on May 9 and was admitted to hospital ...
...of Neurology finds conventionally recommended cour...ng nervous system Lyme disease. However, there is...ith antibiotics has any benefit in treating sympto... American Academy of Neurology. Lyme dise...
...ssive prostate cancer is an elevated rate of incre...ording to a new study. The study found that a pre...ty, of more than 2 ng/ml/year was strongly associa...tor, such as a biopsy Gleason score greater than 7...
...se II clinical trial suggest that extracorporeal p...tients with clinically active (OR symptomatic) Cr... to immunosuppressants and/or anti-TNF agents. A 5...ientific research session of Digestive Disease Wee...
...ination of their stock against bird flu, but use o...at risks, experts warn. Nigeria to date has...5N1.Through culling, quarantine, disinfecting and ...ficer of the Food and Agriculture Organisation (FA...
...abors downpayment on a promise to bridge the 17-ye...on-Indigenous Australians. Its admirable ... closing the gap if his party wins Government, Dr ...aikerwal said Labors commitment of $112 million to...
Other Medicine News:Health News:Antibiotics Highly Effective for Treating Lyme Disease 2Health News:High Pretreatment PSA Velocity Predicts Worse Outcome 2Health News:ECP may Be Effective in Treating Crohn's Disease 2Health News:Concern Expressed Over Poor Quality Bird Flu Vaccine Used in Nigeria 2
(Date:11/9/2009)... , SUNNYVALE, Calif., Nov. 9 ...f studies investigating the effectiveness and safe...r® System, and how this new procedure will im...ter at the 2009 Annual Meeting of the American Col... Miami Beach, Fla. ,, The poster, titled "Where...
(Date:11/9/2009)... , NATICK, Mass., Nov. 9 /PRNewswire-FirstCal...today announced the launch of its COGNIS® car...D) and TELIGEN® implantable cardioverter defi...oved by the Japanese Ministry of Health, Labor and...nt approval in September. COGNIS and TELIGEN are ...
(Date:11/9/2009)... , MIAMI, Nov. 9 IS...nnounced additional results from the Company,s Bep...) 1.5% Phase 3 clinical studies. These results we... Meeting of the American College of Allergy, Asthm..., In a poster presentation titled, "Treatment of...
Breaking Medicine Technology:Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Caliper Life Sciences Launches IVIS 28R 29 In Vivo Imaging System with X Ray 14013 1Caliper Life Sciences Launches IVIS 28R 29 In Vivo Imaging System with X Ray 14013 2Caliper Life Sciences Launches IVIS 28R 29 In Vivo Imaging System with X Ray 14013 3Transave Announces Positive Phase II Results For Once Daily ARIKACE 28TM 29 in the Treatment of Non CF Bronchiectasis Patients Who Have Pseudomonas Lu 4992 1Transave Announces Positive Phase II Results For Once Daily ARIKACE 28TM 29 in the Treatment of Non CF Bronchiectasis Patients Who Have Pseudomonas Lu 4992 2Transave Announces Positive Phase II Results For Once Daily ARIKACE 28TM 29 in the Treatment of Non CF Bronchiectasis Patients Who Have Pseudomonas Lu 4992 3Transave Announces Positive Phase II Results For Once Daily ARIKACE 28TM 29 in the Treatment of Non CF Bronchiectasis Patients Who Have Pseudomonas Lu 4992 4Heart Failure Society of America 13th Annual Scientific Meeting to Focus on a Bench To Bedside Approach 4989 1Heart Failure Society of America 13th Annual Scientific Meeting to Focus on a Bench To Bedside Approach 4989 2Heart Failure Society of America 13th Annual Scientific Meeting to Focus on a Bench To Bedside Approach 4989 3
...s the Importance to Patients of Passing a ...CHMOND, Va., July 22 Insmed Inc. (Nasdaq,CM: INSM...ceuticals, today,announced that Geoffrey Allan, Ph...l briefing on Friday, July 25th, 2008 to discuss t...athway for follow-on,biologics (FOB) and share rec...
...y 22 NicOx S.A.,(Euronext Paris: COX) today annou...of 417 osteoarthritis (OA) patients with controlle...s in the United States, in line with,previously an...sess the,blood pressure profile of naproxcinod, in...mbulatory Blood Pressure Monitoring (ABPM) techniq...
Other Medicine Technology:Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3
Bonaccolto Utility Forceps
Collis Micro Utility Forceps
Straight Tissue Forceps
Sanders-Castroviejo Suturing Forceps
Medicine Products: